LH

In the past six months, Labcorp's stock has experienced several notable events. As of May 8, 2026, the stock price was $253.73. Over the past 30 days, LH was down 6.38%, but up 5.34% over the past 12 months. The 52-week high was $293.72 (October 21, 2025), and the 52-week low was $239.67 (May 15, 2025). Labcorp reported its Q1 2026 earnings on April 30, 2026, with an adjusted EPS of $4.25, beating analyst estimates of $4.09. Revenue for Q1 2026 was $3.54 billion, exceeding estimates of $3.51 billion and representing a 5.8% year-over-year increase. Following these strong results, management raised its full-year 2026 guidance for adjusted EPS to $17.70-$18.35 and revenue guidance to approximately $14.7 billion-$14.8 billion. The company also announced a quarterly dividend of $0.72 per share, payable on June 11, 2026. In February 2026, Labcorp missed Q4 CY2025 sales expectations, though sales still rose 5.6% year-on-year to $3.52 billion. Its non-GAAP profit of $4.07 per share for Q4 CY2025 was above analysts' consensus estimates.